Member Info for MTSparky

44/26b was relinquished due to a lack of prospectively. Good luck HALO !

At this time Centrica and its partner see little prospectivity in the licence, and
elect to let the licence cease.

Licence P1671 was also seen to
contain an extension of the Garnet discovery in which Centrica have an
interest. Evaluation of the Garnet discovery in block 44/27a has established
that whilst the structure containing this discovery extends into the P1671, the
GWC indicates none, or a negligible amount is actually present. No other
prospectivity has been identified.
Hence Centrica and its partner wish to relinquish this licence in its entirety

Looks like this block was previously held by Tullow and Centrica. Needs further reading later ...;o))
https://itportal.ogauthority.co.uk/web_files/relinqs/p1671.pdf
https://itportal.ogauthority.co.uk/web_files/relinqs/p1184.pdf

Above £1 would be amazing. Can't wait for the updates and test results to roll in..;o))..If seller persists we might get another stab at a bargain sub 40p entry here.

Tech analysis of the SP shows good consolidation at this level. Some good wealth creative news and subsequent volume should get us easily past 60p/sh IMO. This would still only value the company at £38m which considering the expected updated resource at Empire alone would still look cheap....;o)) That is my theory anyway !!

Maybe the penny finally is dropping. The potential future value of 4D is staggering..;o))

106.00 - 107.00 (GBX) at 09:29:58 on Market (LSE)

There is no fking way 2Daman is invested in PXC. Seen it all before. Bash the company then say they are invested, then continue to cast doubt over the project. Get a life !!

Commodities all positive this morning which is nice to see. Copper price looks to be making a continuous rise upwards. Iron ore is making a move north too, I am positioned in FXPO to take advantage, target £2.60. Anyone else in FXPO?

Thanks RightOn great work. You might need a bigger calculator for your weekly valuations by the sounds of it !....;o)))

Well for what it is worth, I think the potential for 4d is huge. A cancer treatment with no side effects will transform end of life care and a whole range of other illness. The NASDAQ listing could really ramp things up. No clue where the SP will go today but through the Autumn the value should increase with other news flow to come. 4D are out there on their own aren't they? Ground breaking treatments.

SP is all over the place. If we get into 80p i'll pile in otherwise wait it out. Whats your strategy here folks ?

A drug that treats cancer tumours with NO SIDE EFFECTS is PRICELESS...;o))

....after such a big rise. Sp looks like its consolidating and ready for another push onward in its own time. Today's RNS underpins the company value for me so i'll gladly add on any major pull back or wait for next news to kick us on some more. Should be a good watch through the miserable Autumn months...;o))) FXPO also looking ripe for a kick on through the Autumn.

I am buying on any dips in SP. Hopefully the SP will re-rate in the coming Autumn. £2.60/sh target.

I would imagine today's RNS puts a solid floor on the company value and will build from here..;o))

Just looking at the trades coming through it looks like some consolidation then hopefully the SP will push on. M/C looks like there is some room for additional value to be added. Looking good from here IMO...;o))

PXC will be earning free cash flow from sales such that any debt will be paid off by 2024 (from Red Star Silver alone!).....

After raising ca.$2.54m in equity finance in 2019, we expect PXC to raise a further $3.0m in 2020 and $6.5m in 2021. In terms of financing mine construction/working capital and corporate expenses in 2021, we are assuming that the ca.$32.5m aggregate cost is financed on an 80:20 debt:equity basis.

PXC has previously indicated its aim of minimising the amount of equity issuance in favour of debt and, potentially, other types of project finance – for example production offtake deals. The company has appointed a specialist mining finance firm, Medea Natural Resources, as its lead financial adviser to arrange project financing, and discussions with potential investors have been taking place.

I would suggest anyone thinking of investing in PXC should read the hardman & Co report by Paul Mylchreest dated 14th May 2020. It gives a very good summary of why PXC value should rise significantly over the coming months. The report only gives valuations for Silver at Red Star and Copper at Empire based on what sampling had been done at that time. The valuation back then equates to about £1.08p/sh. I would imagine that the updated resources data and associated bankable feasibility study due this Autumn should see quite a good re-rate in valuation from £1.08p/sh.

Well *large tut* you can lead a horse to water and all that.

So true. The copper and skarn deposits likened to Antamina is mind blowing. I would like to see an update from Paul Mylchreest at Hardman & Co. He can put some legitimate revised numbers on the assets...;o)) The silver at Red Star alone was valued at ~80p/sh, so his revised valuations will make a very interesting read !!